Fortis in talks with investors for SRL Diagnostics
After the announcement, the company's stock closed at Rs 174.90 on BSE, up 11.72% from its previous close.
Fortis Healthcare has said it is in talks with a number of investors to facilitate an exit by the existing PE investors from the company's diagnostic arm SRL.
"The company is in the process of facilitating a third-party exit for the existing private equity investors in SRL Ltd," Fortis Healthcare said in a filing to BSE.
The process is on and the company is in dialogue with a number of investors who have evinced interest, it added.
"As on date, there is no firm proposal under consideration of the management," Fortis Healthcare said.
It, however, did not elaborate.
After the announcement, the company's stock closed at Rs 174.90 on BSE, up 11.72% from its previous close.